Equitable Holdings Flags Merger Lawsuits and Supplements Proxy Ahead of July 30 Vote
EQH sits 40% above its 52-week low of $35.195 on light trading volume (0.4× avg).
Summary
Equitable Holdings disclosed three stockholder lawsuits seeking to enjoin its merger with Corebridge and voluntarily supplemented its proxy with additional details to address alleged disclosure deficiencies ahead of the July 30 stockholder vote.
Key Events · Legal and Risk Events · EQH
-
Three Merger Lawsuits Filed
On July 8 and 10, 2026, stockholders filed complaints in New York and New Jersey courts alleging the definitive proxy omitted material information, seeking injunctions against the July 30 vote and/or rescission of the merger.
-
Supplemental Proxy Disclosures
To moot the allegations, Equitable voluntarily added details on the New Blackstone Stockholders Agreement, governance discussions, and financial advisor analyses—including discount rates, terminal multiples, and per-share valuation ranges.
-
Board Reaffirms Merger Recommendation
The Equitable board continues to unanimously recommend stockholders vote FOR the merger agreement proposal, advisory compensation proposal, and adjournment proposal.
-
Vote Scheduled July 30
Special meetings of Equitable and Corebridge stockholders to approve the merger are set for July 30, 2026; the outcome may be influenced by the litigation and supplemental disclosures.
Analysis · EQH · Finance
With the Corebridge merger vote set for July 30, three stockholder lawsuits filed in early July seek to block the vote or unwind the deal, alleging material omissions in the proxy. While Equitable denies the claims, it is voluntarily adding supplemental disclosures—including details on a new Blackstone stockholders agreement, governance discussions, and financial advisor analyses—to moot the allegations and avoid delays. This late-stage litigation and disclosure update could influence the outcome.
At the time of this filing, EQH was trading at $49.13 on NYSE in the Finance sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $35.20 to $55.24. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.